COMMUNIQUÉS West-GlobeNewswire

uniQure Announces FDA Orphan Drug Designation for AMT-130 in Huntington's disease
06/10/2017
~ First Investigational Gene Therapy in Huntington's Disease to Receive Designation ~ LEXINGTON, Mass. and AMSTERDAM, The Netherlands, Oct. 06, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy [...]
CapMan Buyout to divest Oral Hammaslääkärit to Colosseum Dental Group
06/10/2017
CapMan Buyout press release 6 October 2017 at 11.00 a.m. EEST CapMan Buyout to divest Oral Hammaslääkärit to Colosseum Dental Group A group of investors led by CapMan Buyout, including f unds managed by CapMan Buyout, [...]
Virbac : Déclaration d'actions et de droits de vote au 30 Septembre 2017
06/10/2017
DECLARATION D'ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d'actions composant le capital (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) [...]
Virbac : Declaration of the number of shares and voting rights as of September 2017, 30.
06/10/2017
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
Curetis to Present at Key Investor and Scientific Conferences in the Fourth Quarter 2017
06/10/2017
Curetis to Present at Key Investor and Scientific Conferences in the Fourth Quarter 2017 Amsterdam, the Netherlands, and Holzgerlingen, Germany, October 6, 2017 -- published at 08:00 am CET -- Curetis N.V. (the " [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
06/10/2017
FIT Biotech Oy Company release October 6, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]
Alcon receives CE Mark for first-of-its-kind AutonoMe(TM) preloaded intraocular lens (IOL) delivery system with Clareon® IOL
06/10/2017
AutonoMe (TM) preloaded IOL delivery system provides easy, intuitive control for precise IOL insertion during cataract surgery New Clareon ® IOL in vitro data and early clinical experience to be presented at European [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
06/10/2017
REGULATED INFORMATION GHENT, Belgium, 6 October 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Sanofi : La Cour d'appel ordonne un nouveau procès et annule l'injonction permanente dans le cadre du litige en cours relatif au brevet de Praluent® (alirocumab)
05/10/2017
La Cour d'appel ordonne un nouveau procès et annule l'injonction permanente dans le cadre du litige en cours relatif au brevet de Praluent ® (alirocumab) - Praluent continue d'être accessible aux patients aux États-Unis [...]
Sanofi : Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent® (alirocumab)
05/10/2017
Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent ® (alirocumab) - Praluent continues to be available to patients in the U.S. - Paris, France and Tarrytown, N. [...]
Essilor : Nombre total de droits de vote et d'actions composant le capital social au 30 septembre 2017
05/10/2017
Nombre total de droits de vote et d'actions composant le capital social au 30 septembre 2017 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, [...]
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2017
05/10/2017
Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2017 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité [...]
Summit Therapeutics plc : Exercise of Options
05/10/2017
Summit Therapeutics plc ("Summit" or the "Company") EXERCISE OF SHARE OPTIONS Oxford, UK, 5 October 2017 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery and development company advancing [...]
Final result of the voluntary offer for Weifa ASA
05/10/2017
Following final registration of acceptances, the final acceptance level in Karo Pharma AB's ("Karo Pharma") voluntary offer ("Voluntary Offer") to acquire all shares in Weifa ASA ("Weifa") is 35,463,139 shares [...]
Terveystalo Plc announces the early close of the Public Offering and the Personnel Offering due to oversubscription
05/10/2017
TERVEYSTALO PLC STOCK EXCHANGE RELEASE October 5, 2017 at 4:00 pm NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL [...]
Shire plc : Director/PDMR Shareholding
05/10/2017
Director/PDMR Shareholding October 5, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") Notification of transactions by person discharging managerial responsibilities 1. Details of the person discharging [...]
Orion receives Lean Prize 2016
05/10/2017
ORION CORPORATION PRESS RELEASE 5 OCT 2017 at 12:35 EEST Orion receives Lean Prize 2016 As the cost pressures on pharmaceutical companies increase, Orion needs to constantly improve its efficiency to stay competitive. [...]
DRGT announces results of Phase I study expanding clinical utility of the drug Sirolimus utilizing the company's novel Super-API technology platform
05/10/2017
MSIDA, Malta, Oct. 05, 2017 (GLOBE NEWSWIRE) -- DRGT, a specialty pharmaceutical company, today announced the results of its Phase I study of DRGT18-2, a novel formulation of Sirolimus (Rapamune®), originally a Pfizer [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
05/10/2017
FIT Biotech Oy Company release October 5, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

Pages